Literature DB >> 7519683

Persistence or recurrence of symptoms after transurethral resection of the prostate: a urodynamic assessment.

E K Seaman1, B Z Jacobs, J G Blaivas, S A Kaplan.   

Abstract

Approximately 15 to 20% of patients who undergo transurethral resection of the prostate for benign prostatic hyperplasia have persistent or recurrent voiding symptoms requiring further therapy. To elucidate the etiology of these voiding abnormalities, the urodynamic findings of 129 consecutive men (mean age 72 years) with post-transurethral resection voiding symptoms were retrospectively analyzed with respect to symptoms, uroflowmetry and synchronous video pressure-flow cystometry. Our findings revealed obstruction in 38% of the patients, impaired contractility in 25% and intrinsic sphincter deficiency in 8%. Among 80 patients without neurological disorders involuntary bladder contractions were detected in 50%. However, in 49 patients with neurological disorders involuntary bladder contractions were detected in 76%. This difference was statistically significant. There were 15 patients who failed 2 or more transurethral resections of the prostate, and involuntary bladder contractions were detected in 80%, obstruction in 27%, impaired contractility in 27% and sphincteric incontinence in 20%. Our study reveals residual or recurrent obstruction to be a contributing factor in less than half of all patients who fail transurethral resection of the prostate. Furthermore, patients with a concomitant neurological disorder and those who have undergone more than 1 transurethral resection of the prostate have a significantly higher incidence of involuntary bladder contractions. These results underscore the importance of obtaining complete urodynamic assessment in patients with persistent or recurrent voiding symptoms following transurethral resection of the prostate to guide appropriate therapy.

Entities:  

Mesh:

Year:  1994        PMID: 7519683     DOI: 10.1016/s0022-5347(17)32614-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Latest developments in the assessment and treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: what is clinically relevant?

Authors:  Matthias Oelke
Journal:  Clin Drug Investig       Date:  2015-02       Impact factor: 2.859

Review 2.  The Use of Urodynamics Assessment Before the Surgical Treatment of BPH.

Authors:  Ahmed El-Zawahry; Shaheen Alanee; Angela Malan-Elzawahry
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

3.  Assessment of noninvasive predictors of bladder detrusor underactivity in BPH/LUTs patients.

Authors:  Fei Luo; Hong-Hong Sun; Yan-Hui Su; Zhi-Hua Zhang; Ya-Shen Wang; Zhen Zhao; Jian Li
Journal:  Int Urol Nephrol       Date:  2017-02-15       Impact factor: 2.370

4.  Nocturia: state of the art and critical analysis of current assessment and treatment strategies.

Authors:  Matthias Oelke; Erika Adler; Daniela Marschall-Kehrel; Thomas R W Herrmann; Richard Berges
Journal:  World J Urol       Date:  2014-10       Impact factor: 4.226

Review 5.  Pharmacological methods for the preclinical assessment of therapeutics for OAB: an up-to-date review.

Authors:  Emilio Sacco; Riccardo Bientinesi; Pierfrancesco Bassi; Diego Currò
Journal:  Int Urogynecol J       Date:  2016-02-17       Impact factor: 2.894

6.  Effect of Transurethral Resection of the Prostate on Storage Symptoms in Patients with Benign Prostatic Hyperplasia of Less than 30 ml.

Authors:  Yu Jin Kang; Ki Ho Kim; Youngjin Seo; Kyung Seop Lee
Journal:  World J Mens Health       Date:  2013-04-23       Impact factor: 5.400

Review 7.  Mechanistic insights into the role of alpha1adrenergic receptors in lower urinary tract symptoms.

Authors:  Gregory A Michelotti; Debra A Schwinn
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 2.862

8.  Efficacy and safety of low-dose propiverine in patients with lower urinary tract symptoms/benign prostatic hyperplasia with storage symptoms: a prospective, randomized, single-blinded and multicenter clinical trial.

Authors:  Jae Hyun Bae; Sun Ouck Kim; Eun Sang Yoo; Kyung Hyun Moon; Yoon Soo Kyung; Hyung Jee Kim
Journal:  Korean J Urol       Date:  2011-04-22

9.  Expression of bladder α1-adrenoceptor subtype after relief of partial bladder outlet obstruction in a rat model.

Authors:  Ji Yong Lee; Jong Mok Park; Yong Gil Na; Ki Hak Song; Jae Sung Lim; Seung Woo Yang; Gun Hwa Kim; Ju Hyun Shin
Journal:  Investig Clin Urol       Date:  2020-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.